COVID-19 vaccines: neutralizing antibodies and the alum advantage
Peter J. Hotez, David B. Corry, Ulrich Strych, María Elena Bottazzi
Topics & Concepts
Coronavirus disease 2019 (COVID-19)AdjuvantAlumVirologyNeutralizing antibodyAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakAntibody responseImmunologyMedicineChemistryInfectious disease (medical specialty)OutbreakDiseaseInternal medicineOrganic chemistrySARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesBacterial Infections and Vaccines